Gallbladder cancer rates have been stable or declining for most Americans over the last two decades, but cases have steadily risen among Blacks, with growing numbers not being diagnosed until later stages, according to a study scheduled for presentation at Digestive Disease Week 2024.
Rosemont expands liquid medicine portfolio with Lucis acquisition – Pharmaceutical Technology
The company will develop Lucis’ liquid pipeline products. Source: Shutterstock / Matveev Aleksandr. Oral liquid medicine manufacturer Rosemont Pharmaceuticals has announced the acquisition of Lucis
June 19, 2023